Biocept to Explore Strategic Alternatives and Implement Restructuring Plan

Author's Avatar
Jan 06, 2023

Biocept, Inc. (NasdaqCM: BIOC) today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder value. Biocept has engaged EF Hutton, division of Benchmark Investments, Inc., as its financial advisor to assist in this process.